Taiwan Semiconductor Manufacturing Company (NYSE:TSM) – TSMC exceeded earnings and revenue expectations...
Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy (IgAN...
Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing clinically meaningful and statistically...
– Continued enrollment globally in multiple clinical studies of vepdegestrant in ER+/HER2- metastatic breast...
Apple (NASDAQ:AAPL) – Smartphone shipments from Apple in China fell 19% in the first quarter due to...
New Novartis Fabhalta® (iptacopan) data show clinically meaningful and statistically significant proteinuria reduction of 38.3% versus placebo...
– Arvinas to receive a $150 million upfront payment for the license of ARV-766 and the sale of Arvinas’...
Delta Air Lines (NYSE:DAL) – Delta Airlines reported a first-quarter profit of $37 million, a...
New Novartis data show early addition of twice-yearly* Leqvio® (inclisiran) following maximally tolerated statin therapy significantly reduces...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.